| 1 |
33573565 | The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism? | 2022 |
2 |
| 2 |
32885412 | Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism. | 2021 Apr |
1 |
| 3 |
33931678 | CB1 antagonism increases excitatory synaptogenesis in a cortical spheroid model of fetal brain development. | 2021 Apr 30 |
1 |
| 4 |
34064024 | Role of the Endocannabinoid System in the Adipose Tissue with Focus on Energy Metabolism. | 2021 May 21 |
2 |
| 5 |
34326318 | A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein. | 2021 Jul 29 |
1 |
| 6 |
31917333 | Δ9-tetrahydrocannabinol and 2-AG decreases neurite outgrowth and differentially affects ERK1/2 and Akt signaling in hiPSC-derived cortical neurons. | 2020 Mar |
1 |
| 7 |
31925452 | The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling. | 2020 Nov |
2 |
| 8 |
31981244 | Rimonabant suppresses RNA transcription of hepatitis B virus by inhibiting hepatocyte nuclear factor 4α. | 2020 May |
1 |
| 9 |
32417279 | Behavioral assessment of rimonabant under acute and chronic conditions. | 2020 Jul 15 |
1 |
| 10 |
32512776 | Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs. | 2020 Jun 4 |
1 |
| 11 |
32927872 | A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided. | 2020 Sep 10 |
1 |
| 12 |
33002729 | Chlorotrimethylsilane promoted one-flask heterocyclic synthesis of 1,2,4-triazoles from nitrilimines: Modeling studies and bioactivity evaluation of LH-21 and Rimonabant analogues. | 2020 Nov |
1 |
| 13 |
30649023 | Cannabis effects on lipoproteins. | 2019 Apr |
1 |
| 14 |
30687889 | Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson's Disease. | 2019 Aug |
2 |
| 15 |
31284863 | Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. | 2019 |
1 |
| 16 |
31469511 | The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept. | 2019 Nov |
1 |
| 17 |
31564385 | Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probes. | 2019 Nov 1 |
5 |
| 18 |
28661046 | Activation of CaMKKβ/AMPKα pathway by 2-AG in human platelets. | 2018 Jan |
2 |
| 19 |
29407764 | Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor. | 2018 May 1 |
3 |
| 20 |
29417597 | Acute Ethanol Inhibition of Adult Hippocampal Neurogenesis Involves CB1 Cannabinoid Receptor Signaling. | 2018 Apr |
2 |
| 21 |
29551963 | Cannabinoid Receptors Modulate Excitation of an Olfactory Bulb Local Circuit by Cortical Feedback. | 2018 |
2 |
| 22 |
29792186 | Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma. | 2018 May 23 |
1 |
| 23 |
30077609 | Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists. | 2018 Aug 15 |
1 |
| 24 |
30262909 | Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy. | 2018 Sep 27 |
1 |
| 25 |
30460698 | Anandamide Induces Platelet Nitric Oxide Synthase through AMP-Activated Protein Kinase. | 2018 Sep |
1 |
| 26 |
28222356 | Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus. | 2017 Jul |
1 |
| 27 |
28564576 | The endocannabinoid system as a target for addiction treatment: Trials and tribulations. | 2017 Sep 15 |
2 |
| 28 |
28947487 | Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors. | 2017 Dec |
1 |
| 29 |
29308855 | [Prospects for the Use of Cannabinoid Receptor Ligands for the Treatment of Metabolic Syndrome and Atherosclerosis: Analysis of Experimental and Clinical Data]. | 2017 |
1 |
| 30 |
29354056 | Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids. | 2017 |
1 |
| 31 |
26123153 | Roles for the endocannabinoid system in ethanol-motivated behavior. | 2016 Feb 4 |
2 |
| 32 |
26803499 | Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys. | 2016 May |
1 |
| 33 |
27208730 | Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin. | 2016 Jun |
1 |
| 34 |
25411367 | (4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs. | 2015 Feb |
4 |
| 35 |
25859226 | Role of the endogenous cannabinoid system in nicotine addiction: novel insights. | 2015 |
2 |
| 36 |
25893829 | Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines. | 2015 Dec |
1 |
| 37 |
26008966 | Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells. | 2015 Jun 20 |
4 |
| 38 |
26157624 | Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling. | 2015 |
2 |
| 39 |
26362774 | The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers. | 2015 Sep 10 |
1 |
| 40 |
26365347 | N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. | 2015 Oct 23 |
1 |
| 41 |
23452341 | The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. | 2014 Jan |
1 |
| 42 |
24366865 | Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling. | 2014 Feb 28 |
1 |
| 43 |
24467410 | Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors. | 2014 Jun |
1 |
| 44 |
24692267 | Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa. | 2014 Jul |
1 |
| 45 |
24747288 | Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists. | 2014 May 22 |
1 |
| 46 |
25096297 | Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure. | 2014 Sep 1 |
1 |
| 47 |
25713910 | Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells. | 2014 Oct |
3 |
| 48 |
23070073 | Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity. | 2013 Dec |
1 |
| 49 |
23278450 | LiCABEDS II. Modeling of ligand selectivity for G-protein-coupled cannabinoid receptors. | 2013 Jan 28 |
2 |
| 50 |
23287700 | Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists. | 2013 Mar |
1 |